-
公开(公告)号:US20130052281A1
公开(公告)日:2013-02-28
申请号:US13591859
申请日:2012-08-22
申请人: William FARNABY , Charlotte FIELDHOUSE , Catrina KERR , Natasha KINSELLA , David LIVERMORE , Kevin MERCHANT , David MILLER , Katherine HAZEL
发明人: William FARNABY , Charlotte FIELDHOUSE , Catrina KERR , Natasha KINSELLA , David LIVERMORE , Kevin MERCHANT , David MILLER , Katherine HAZEL
IPC分类号: C07D237/16 , C07D401/06 , C07D237/18 , A61K31/50 , A61K31/501 , C07D405/06 , C07D237/22 , A61K31/55 , A61K31/5513 , A61K31/554 , A61K31/53 , A61K31/519 , A61K33/00 , A61P25/18 , A61P25/00 , A61P29/00 , C07F7/10
CPC分类号: A61K31/50 , A61K31/501 , A61K45/06 , C07D237/16 , C07D237/18 , C07D237/22 , C07D401/06 , C07D401/10 , C07D405/06 , C07D407/10 , C07F7/0812
摘要: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
摘要翻译: 本发明提供式(I)化合物及其药学上可接受的盐,其中R1和R2如说明书中所定义,其制备方法,含有它们的药物组合物及其在治疗中的用途。